AVNT
AVIENT CORP
Next earnings Jul 30, 2026 · consensus $0.91 EPS, $912M rev
Last earnings -3.5% on 2026-05-07
$37.31
▲ +1.28%$37.31▲ +17.25%
over 1Y
L $26.82H $42.61
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+1.3%
1W+0.8%
1M+6.8%
3M+7.2%
YTD+19.5%
1Y+17.2%
Hold
Conviction
Horizon
Medium (3–12mo)
12-mo target
$•••
Street · 14 analysts
Buy
Specialty plastics turnaround stalling — flat sales, halved earnings and a 41x P/E leave little room for error.
Revenue $3.26B · FY2025
The read
Middling fundamentals and a rich price (~83% above fair value) leave little margin of safety — a wait-and-see.
Avient's FY2025 results show a business stuck in low gear. Sales of $3.26B grew just 0.6% (and -0.3% ex-FX per MD&A), while operating income collapsed 38.2% to $204M and net income fell 51.7% to $81.9M as SG&A jumped $84.7M (+11.6%) and cost of sales rose 2.8% against barely-positive revenue. Gross margin compressed 140bp to 31.2% and ROE is a thin 3.4% — this is not the profile of the 'innovator of materials solutions' the MD&A describes, and the 'growth vector' wins in defense/healthcare aren't yet visible in the consolidated print.
The balance sheet is workable but not pristine: $1.92B long-term debt against $2.37B equity and $511M cash, with current liabilities up 11.9% even as current assets shrank. Operating cash flow of $302M (+17.4%) comfortably funds $107M capex and the $98.8M dividend, so the payout is safe — but with FY2025 net income of only $81.9M, the company is paying out more than it earned, leaving no cushion for buybacks (zero in FY2024) or debt paydown beyond the modest 6.6% reduction achieved.
Is AVNT a buy? The one-page verdict, explained →
The options angle
model · matches our verdictCovered call~60d expiry
- Long 100 shares @ ~37.31
- Short call 39 @ ~1.58 est
debit $3,573max +$327max −$3,572BE 35.73
HOLD means own it, don't chase it — harvesting premium against the position matches the verdict.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $3.32B | $3.40B | $3.14B | $3.24B | $3.26B |
| Gross profit | $944M | $883M | $893M | $1.06B | $1.02B |
| Operating income | $280M | $243M | $197M | $329M | $204M |
| Net income | $231M | $703M | $75.7M | $170M | $81.9M |
| Diluted EPS | $2.51 | $7.63 | $0.83 | $1.84 | $0.89 |
| Net margin | 7.0% | 20.7% | 2.4% | 5.2% | 2.5% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$4.83B
EV / EBITDA12.4
EV / Sales1.5
EV / FCF24.8
P / FCF17.5
PEG (trailing)—
Earnings yield2.4%
FCF yield5.7%
Quality & risk
ROIC (est.)3.7%
Free cash flow$195M
Total debt$1.92B
Net cash-$1.41B
Piotroski F-Score4/9
Capital returns
Buyback yield0.0%
Dividend yield (est.)2.9%
Shareholder yield2.9%
Shares Δ YoY+0.2%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsRecent disclosure tone has skewed negative — read the flagged items.
- 8-K Shareholder vote2026-05-15
Annual meeting vote results; directors elected, routine governance outcomes disclosed
- 8-K Earnings results2026-05-07
Q1 2026 10-Q detailed continued operating-margin softness and cost headwinds
- 10-Q Quarterly report2026-05-07
Q1 2026 10-Q detailed continued operating-margin softness and cost headwinds
- 8-K Officer / director change2026-04-27
Executive/director change disclosed; leadership transition during weak earnings
- DEF 14A Proxy statement2026-03-27
2026 proxy: routine board slate, exec comp items; no major governance shifts
- 10-K Annual report2026-02-17
FY2025: sales +0.6%, op income -38%, net income -52%; SG&A +12% hit margins
- 8-K Earnings results2026-02-12
FY2025 EPS $0.89 vs $1.84; net income halved on -38% operating income drop
- 8-K Earnings results2025-11-05
Q3 2025 10-Q: gross margin slid from 32.6% peak; SG&A growth pressured profit
- 10-Q Quarterly report2025-11-05
Q3 2025 10-Q: gross margin slid from 32.6% peak; SG&A growth pressured profit
Recent filings
all on EDGAR ↗4Period ending 2026-06-302026-07-02open ↗4Period ending 2026-06-302026-07-02open ↗4Period ending 2026-06-302026-07-02open ↗4Period ending 2026-06-302026-07-02open ↗4Period ending 2026-06-302026-07-02open ↗4Period ending 2026-06-302026-07-02open ↗4Period ending 2026-06-302026-07-02open ↗4Period ending 2026-06-302026-07-02open ↗4Period ending 2026-06-302026-07-02open ↗4Period ending 2026-06-302026-07-02open ↗11-KPeriod ending 2025-12-312026-06-23open ↗4Period ending 2026-06-012026-06-02open ↗
Frequently asked
- Is AVIENT CORP (AVNT) a buy?
- AVNT currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. Specialty plastics turnaround stalling — flat sales, halved earnings and a 41x P/E leave little room for error.
- What is AVNT's fair value?
- A Modified-Graham model based on AVNT's SEC fundamentals estimates a fair value of about $6.47. It is an estimate from reported earnings, not a price target.
- Is AVNT overvalued or undervalued?
- Against a Modified-Graham fair-value estimate, AVNT currently appears overvalued relative to its SEC-grounded earnings power.
- What is AVIENT CORP's quality score?
- AVNT scores 57.24899381953811/100 (grade C) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001122976, latest 10-Q filed 2026-05-07) · EODHD · Proprietary analysis · as of 6/25/2026, 1:41:16 PM.
About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 25, 2026, 9:41 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.